一分钟看懂
这是一项关于淋巴瘤的III 期研究，登记的药物或干预包括Zanubrutinib；Rituximab；Lenalidomide；Obinutuzumab，当前状态为研究进行中，已停止招募。登记地点显示中国芜湖、北京、重庆、福州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Zanubrutinib；Rituximab；Lenalidomide；Obinutuzumab · III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- The First Affiliated Hospital of Wannan Medical College · 芜湖
- Beijing Friendship Hospital, Capital Medical University · 北京
- Beijing Cancer Hospital · 北京
- Beijing Friendship Hospital, Capital Medical University(Tongzhou) · 北京
- Chongqing Cancer Hospital · 重庆
- Fujian Medical University Union Hospital · 福州
- The First Affiliated Hospital of Xiamen University · 厦门
- The First Peoples Hospital of Foshan · 佛山
- Sun Yat Sen University Cancer Center · 广州
- Huizhou Central Peoples Hospital · 惠州
- Meizhou People Hospital · 梅州
- Affiliated Hospital of Guangdong Medical University · 湛江
- Harbin Medical University Cancer Hospital · 哈尔滨
- Anyang Tumor Hospital · 安阳
- Henan Cancer Hospital · 郑州
- Union Hospital of Tongji Medical College, Huazhong University of Science and Technology · 武汉
- Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology · 武汉
- The First Peoples Hospital of Changde City · 常德
- Jiangsu Province Hospital · 南京
- Affiliated Hospital of Nantong University · 南通
- The First Affiliated Hospital of Soochow University · 苏州
- Wuxi Peoples Hospital · 无锡
- The First Affiliated Hospital of Nanchang University Branch Donghu · 南昌
- Jiangxi Province Cancer Hospital · 南昌
- The First Affiliated Hospital of Nanchang University Branch Xianghu · 南昌
- The First Hospital of Jilin University · 长春
- Shengjing Hospital of China Medical University · 沈阳
- Liaoning Cancer Hospital and Institute · 沈阳
- Peoples Hospital of Rizhao · 日照
- The Second Affiliated Hospital of Shandong First Medical University · 泰安
- Fudan University Shanghai Cancer Center · 上海
- Shanxi Provincial Cancer Hospital · 太原
- West China Hospital, Sichuan University · 成都
- Dongyang Peoples Hospital · 东阳
- Zhejiang Cancer Hospital · 杭州
- The First Hospital of Jiaxing · 嘉兴
- Jinhua Municipal Central Hospital · 金华
- The First Affiliated Hospital of Wenzhou Medical University · 温州
公开的入选条件
- * Histologically confirmed grade 1-3a FL or MZL
- * Previously treated with ≥ 1 line of systemic therapy including anti-CD20 agent. Must have a documented failure to achieve at least partial response during the most recent systemic therapy or documented progressive disease after the most recent systemic thera
- * Need for systemic therapy for FL or MZL
- * Measurable disease by computed tomography or magnetic resonance imaging
- * Adequate bone marrow, liver and renal function
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT05100862；登记信息更新于 2026-09-11。